2015
DOI: 10.1016/j.rec.2014.10.022
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…European authors have stated that the most ominous prognoses are associated with two or more risk factors. Amiodarone is used when the IAD is not available or when the patient refuses its implantation [25].…”
Section: Hypertrophic Cardiomyopathy (Hcm)mentioning
confidence: 99%
See 1 more Smart Citation
“…European authors have stated that the most ominous prognoses are associated with two or more risk factors. Amiodarone is used when the IAD is not available or when the patient refuses its implantation [25].…”
Section: Hypertrophic Cardiomyopathy (Hcm)mentioning
confidence: 99%
“…LQTS is a heart disease that can be classified within the so-called "channelopa- There is no cure for this disease, and no treatment can restore the QT interval to normal values. However, beta-blockers and/or an IAD (depending on the patient) can help to prevent SD events and notably improve patients' chances for survival [25].…”
Section: Long Qt Syndrome (Lqts)mentioning
confidence: 99%